NCT00495313View on ClinicalTrials.gov

Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Rosacea
Interventions
DRUG

doxycycline

COL-101, QD plus metronidazole

DRUG

doxycycline

40 mg with metronidazole QD

Trial Locations (7)

68144

Joel Schlessinger, Omaha

75230

William Abramovits, Dallas

76011

Angela Moore, Arlington

84088

Douglas Forsha, West Jordan

89052

James Del Rosso, Las Vegas

98101

Bernard Goffe, Seattle

99204

William Werschler, Spokane

Sponsors
All Listed Sponsors
lead

CollaGenex Pharmaceuticals

INDUSTRY

NCT00495313 - Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens | Biotech Hunter | Biotech Hunter